Trials / Completed
CompletedNCT05561543
Effects of Peppermint Oil in Mild-moderate Hypertension.
Effects of Peppermint Oil in Cardiometabolic Outcomes in Participants With Mild-moderate Hypertension.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Central Lancashire · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Cardiovascular and associated hypertensive diseases are the leading health burden and cause of mortality worldwide; therefore, the necessity for effective interventions is paramount. Dietary interventions to improve cardiovascular health are highly sought after as they possess less risk and financial burden than pharmacological drugs. Our previous randomized trial has shown that oral peppermint can improving systolic blood pressure and other cardiovascular/ blood lipids in healthy individuals. However, to date, no research has explored this using a placebo randomized intervention in patients with hypertension. Therefore, the primary purpose of the proposed investigation is to test the ability of oral peppermint oil supplementation to improve cardiometabolic parameters in participants with mild-moderate hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Peppermint oil | Peppermint oil |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-08-01
- Completion
- 2025-08-10
- First posted
- 2022-09-30
- Last updated
- 2026-01-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05561543. Inclusion in this directory is not an endorsement.